Venenum BioDesign
Biotechnology Research • 
Robbinsville, New Jersey, United States • 21-50 Employees
Company overview
| Headquarters | 8 Black Forest Rd, Hamilton, NJ 08691, US |
| Phone number | +16095701046 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Drug Discovery, Medicinal Chemistry, High Throughput Screening, Compound Management, In Vivo Pharmacology, Admet-Pk |
| Founded | 2009 |
| Employees | 21-50 |
| Socials |
Key Contact at Venenum BioDesign
Eli Mordechai
Ceo
Venenum BioDesign Email Formats
Venenum BioDesign uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@venenumbiodesign.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@venenumbiodesign.com | 100% |
About Venenum BioDesign
VENENUM Biodesign, a Genesis Drug Discovery and Development (GD3) Company, is focused on discovering and advancing innovative new medicines for significant unmet medical needs in key therapeutic areas, including; cancer, inflammation, infectious diseases, metabolic diseases, and women’s health. Our most advanced programs are targeting Clostridium difficile infection (CDI) and Type 2 Diabetes (T2D). Our business model allows us to focus on the creation of high value, innovative small molecule programs against well-validated targets, as well as new targets identified from our own research and to work with partners for clinical and commercial development to bring our products to patients. Our mission is to improve patients’ lives through the discovery of therapeutic compounds against our novel biological targets. Many of our targets involve novel protein-protein or protein-DNA interactions. Others are more conventional target classes e.g., GPCRs and enzymes. Our goal is to advance our discoveries to medicine through partnership with pharmaceutical companies. We utilize state-of-the-art assay development and ultra-high throughput screening (UHTS) against our proprietary 6 million ECLiPS compound collection in conjunction with protein engineering and structural biology, medicinal chemistry, and in vivo models.
Venenum BioDesign revenue & valuation
| Annual revenue | $500,000 |
| Revenue per employee | $20,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Venenum BioDesign has 13 employees across 5 departments.
Departments
Number of employees
Funding Data
Venenum BioDesign has never raised funding before.
Venenum BioDesign Tech Stack
Discover the technologies and tools that power Venenum BioDesign's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Hosting
Reverse proxies
Programming languages
JavaScript libraries
CDN
Miscellaneous
UI frameworks
Analytics
Maps
Font scripts
Spain
Mexico
United Kingdom
Frequently asked questions
4.8
40,000 users
